Tag Archives: Medicare Part D

Obesity is a risk factor for cancer, heart disease stroke and diabetes. Thus, drugs like semaglutides (Wegovy, Ozempic) don’t just reduce weight in the obese, they also reduce risk of cancer, heart disease, stroke and diabetes, which are huge health care burdens. It’s good to see that Medicare is finally coming to grips with this obvious fact:“On March 8, 2024, FDA approved Wegovy (semaglutide) to treat cardiovascular disease risks — heart attack,...

I am late on the draw for this information on Medicare. Been busy with other issues. Had dinner last night at VA’ Bene, a restaurant in Chandler which is not too far from us. An older couple joined us afterwards as we were sipping some Chianti. The heat finally got to this couple and they are moving back to Oregon after living here for twenty years. Medicare Part D in 2024: A First Look at Prescription Drug Plan Availability, Premiums, and Cost...